nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Ethinyl Estradiol—prostate cancer	0.195	0.74	CrCtD
Danazol—GNRHR—Degarelix—prostate cancer	0.0858	0.34	CbGbCtD
Danazol—Prednisone—prostate cancer	0.0684	0.26	CrCtD
Danazol—GNRHR—Goserelin—prostate cancer	0.0493	0.195	CbGbCtD
Danazol—SHBG—prostate cancer	0.0443	0.275	CbGaD
Danazol—AR—prostate cancer	0.0389	0.241	CbGaD
Danazol—CYP19A1—prostate cancer	0.0325	0.202	CbGaD
Danazol—ESR1—prostate cancer	0.03	0.186	CbGaD
Danazol—CYP3A4—prostate cancer	0.0153	0.0949	CbGaD
Danazol—AR—Bicalutamide—prostate cancer	0.0144	0.0569	CbGbCtD
Danazol—AR—Nilutamide—prostate cancer	0.0144	0.0569	CbGbCtD
Danazol—Testosterone—Abiraterone—prostate cancer	0.0122	0.0571	CrCrCtD
Danazol—AR—Flutamide—prostate cancer	0.0119	0.0472	CbGbCtD
Danazol—ESR1—Estramustine—prostate cancer	0.0116	0.0458	CbGbCtD
Danazol—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.0111	0.052	CrCrCtD
Danazol—Trilostane—Estradiol—prostate cancer	0.0104	0.0486	CrCrCtD
Danazol—SHBG—Estrone—prostate cancer	0.0103	0.0408	CbGbCtD
Danazol—Quinestrol—Estramustine—prostate cancer	0.00994	0.0464	CrCrCtD
Danazol—Mestranol—Estramustine—prostate cancer	0.00994	0.0464	CrCrCtD
Danazol—Ethinyl Estradiol—Estramustine—prostate cancer	0.00947	0.0442	CrCrCtD
Danazol—SHBG—Ethinyl Estradiol—prostate cancer	0.00918	0.0363	CbGbCtD
Danazol—Formestane—Estrone—prostate cancer	0.00832	0.0388	CrCrCtD
Danazol—Mestranol—Estrone—prostate cancer	0.0079	0.0369	CrCrCtD
Danazol—Quinestrol—Estrone—prostate cancer	0.0079	0.0369	CrCrCtD
Danazol—Desogestrel—Ethinyl Estradiol—prostate cancer	0.00789	0.0368	CrCrCtD
Danazol—Ethinyl Estradiol—Estrone—prostate cancer	0.00753	0.0351	CrCrCtD
Danazol—ESR1—Estrone—prostate cancer	0.00745	0.0295	CbGbCtD
Danazol—Formestane—Conjugated Estrogens—prostate cancer	0.00732	0.0342	CrCrCtD
Danazol—Quinestrol—Conjugated Estrogens—prostate cancer	0.00696	0.0325	CrCrCtD
Danazol—Mestranol—Conjugated Estrogens—prostate cancer	0.00696	0.0325	CrCrCtD
Danazol—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.00689	0.0321	CrCrCtD
Danazol—ESR1—Ethinyl Estradiol—prostate cancer	0.00664	0.0263	CbGbCtD
Danazol—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.00663	0.0309	CrCrCtD
Danazol—Etonogestrel—Ethinyl Estradiol—prostate cancer	0.0065	0.0303	CrCrCtD
Danazol—Norelgestromin—Ethinyl Estradiol—prostate cancer	0.00615	0.0287	CrCrCtD
Danazol—Mestranol—Estradiol—prostate cancer	0.00599	0.0279	CrCrCtD
Danazol—Quinestrol—Estradiol—prostate cancer	0.00599	0.0279	CrCrCtD
Danazol—SHBG—Estradiol—prostate cancer	0.00592	0.0234	CbGbCtD
Danazol—Mestranol—Ethinyl Estradiol—prostate cancer	0.00584	0.0273	CrCrCtD
Danazol—Quinestrol—Ethinyl Estradiol—prostate cancer	0.00584	0.0273	CrCrCtD
Danazol—Ethinyl Estradiol—Estradiol—prostate cancer	0.0057	0.0266	CrCrCtD
Danazol—Testolactone—Estrone—prostate cancer	0.0052	0.0243	CrCrCtD
Danazol—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.00509	0.0238	CrCrCtD
Danazol—Testosterone—Estramustine—prostate cancer	0.00509	0.0237	CrCrCtD
Danazol—AR—Estradiol—prostate cancer	0.00495	0.0196	CbGbCtD
Danazol—ESR1—Conjugated Estrogens—prostate cancer	0.00487	0.0193	CbGbCtD
Danazol—ESR1—Estradiol—prostate cancer	0.00428	0.0169	CbGbCtD
Danazol—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00409	0.0191	CrCrCtD
Danazol—Testosterone—Estrone—prostate cancer	0.00404	0.0189	CrCrCtD
Danazol—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.00336	0.0157	CrCrCtD
Danazol—Testosterone—Estradiol—prostate cancer	0.00306	0.0143	CrCrCtD
Danazol—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00243	0.00962	CbGbCtD
Danazol—SHBG—semen—prostate cancer	0.00184	0.112	CbGeAlD
Danazol—CYP19A1—semen—prostate cancer	0.00149	0.0909	CbGeAlD
Danazol—Cortisone acetate—Prednisone—prostate cancer	0.00139	0.00649	CrCrCtD
Danazol—AR—penis—prostate cancer	0.00139	0.0844	CbGeAlD
Danazol—Testolactone—Prednisone—prostate cancer	0.00135	0.0063	CrCrCtD
Danazol—AR—semen—prostate cancer	0.00132	0.0805	CbGeAlD
Danazol—CYP3A4—Bicalutamide—prostate cancer	0.00128	0.00505	CbGbCtD
Danazol—CYP3A4—Estramustine—prostate cancer	0.00119	0.0047	CbGbCtD
Danazol—Methyltestosterone—Prednisone—prostate cancer	0.00118	0.0055	CrCrCtD
Danazol—CYP3A4—Abiraterone—prostate cancer	0.00106	0.00419	CbGbCtD
Danazol—CYP3A4—Flutamide—prostate cancer	0.00106	0.00419	CbGbCtD
Danazol—Hydrocortisone—Prednisone—prostate cancer	0.000986	0.0046	CrCrCtD
Danazol—CCL2—prostate gland—prostate cancer	0.000792	0.0482	CbGeAlD
Danazol—CYP3A4—Cabazitaxel—prostate cancer	0.000783	0.0031	CbGbCtD
Danazol—CYP3A4—Estrone—prostate cancer	0.000765	0.00303	CbGbCtD
Danazol—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000682	0.0027	CbGbCtD
Danazol—CCL2—seminal vesicle—prostate cancer	0.00067	0.0407	CbGeAlD
Danazol—CCL2—epithelium—prostate cancer	0.000582	0.0354	CbGeAlD
Danazol—CCL2—renal system—prostate cancer	0.00054	0.0328	CbGeAlD
Danazol—CCL2—urethra—prostate cancer	0.00053	0.0323	CbGeAlD
Danazol—CYP3A4—urine—prostate cancer	0.000506	0.0308	CbGeAlD
Danazol—CYP3A4—Conjugated Estrogens—prostate cancer	0.0005	0.00198	CbGbCtD
Danazol—SHBG—prostate gland—prostate cancer	0.000462	0.0281	CbGeAlD
Danazol—CYP3A4—Mitoxantrone—prostate cancer	0.000455	0.0018	CbGbCtD
Danazol—GNRHR—testis—prostate cancer	0.000447	0.0272	CbGeAlD
Danazol—CYP3A4—Estradiol—prostate cancer	0.000439	0.00174	CbGbCtD
Danazol—PGR—prostate gland—prostate cancer	0.000416	0.0253	CbGeAlD
Danazol—CCL2—bone marrow—prostate cancer	0.000408	0.0248	CbGeAlD
Danazol—CYP3A4—Prednisone—prostate cancer	0.000378	0.0015	CbGbCtD
Danazol—CYP19A1—prostate gland—prostate cancer	0.000374	0.0228	CbGeAlD
Danazol—CCL2—testis—prostate cancer	0.000349	0.0212	CbGeAlD
Danazol—AR—prostate gland—prostate cancer	0.000331	0.0202	CbGeAlD
Danazol—ESR1—prostate gland—prostate cancer	0.000325	0.0198	CbGeAlD
Danazol—PGR—epithelium—prostate cancer	0.000306	0.0186	CbGeAlD
Danazol—CYP3A4—Etoposide—prostate cancer	0.000287	0.00114	CbGbCtD
Danazol—AR—seminal vesicle—prostate cancer	0.00028	0.0171	CbGeAlD
Danazol—CYP3A4—Docetaxel—prostate cancer	0.000262	0.00104	CbGbCtD
Danazol—CCL2—lymph node—prostate cancer	0.000253	0.0154	CbGeAlD
Danazol—AR—epithelium—prostate cancer	0.000244	0.0148	CbGeAlD
Danazol—ESR1—epithelium—prostate cancer	0.000239	0.0146	CbGeAlD
Danazol—SHBG—bone marrow—prostate cancer	0.000238	0.0145	CbGeAlD
Danazol—Trilostane—HSD3B1—prostate cancer	0.000236	0.127	CrCbGaD
Danazol—AR—renal system—prostate cancer	0.000226	0.0137	CbGeAlD
Danazol—AR—urethra—prostate cancer	0.000222	0.0135	CbGeAlD
Danazol—ESR1—renal system—prostate cancer	0.000222	0.0135	CbGeAlD
Danazol—SHBG—testis—prostate cancer	0.000203	0.0124	CbGeAlD
Danazol—CYP3A4—Doxorubicin—prostate cancer	0.000196	0.000774	CbGbCtD
Danazol—PGR—testis—prostate cancer	0.000183	0.0112	CbGeAlD
Danazol—CYP19A1—testis—prostate cancer	0.000165	0.01	CbGeAlD
Danazol—Trilostane—HSD3B2—prostate cancer	0.000159	0.086	CrCbGaD
Danazol—AR—testis—prostate cancer	0.000146	0.00889	CbGeAlD
Danazol—ESR1—testis—prostate cancer	0.000143	0.00872	CbGeAlD
Danazol—CCL2—Methylprednisolone—Prednisone—prostate cancer	0.000135	0.171	CbGdCrCtD
Danazol—PGR—lymph node—prostate cancer	0.000133	0.00808	CbGeAlD
Danazol—CYP3A4—renal system—prostate cancer	0.000124	0.00753	CbGeAlD
Danazol—CYP19A1—lymph node—prostate cancer	0.00012	0.00728	CbGeAlD
Danazol—CCL2—Amcinonide—Prednisone—prostate cancer	0.000107	0.136	CbGdCrCtD
Danazol—AR—lymph node—prostate cancer	0.000106	0.00644	CbGeAlD
Danazol—ESR1—lymph node—prostate cancer	0.000104	0.00632	CbGeAlD
Danazol—CCL2—Fluorometholone—Prednisone—prostate cancer	8.34e-05	0.106	CbGdCrCtD
Danazol—Levonorgestrel—SRD5A1—prostate cancer	7.65e-05	0.0414	CrCbGaD
Danazol—CCL2—Clobetasol propionate—Prednisone—prostate cancer	7.05e-05	0.0897	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisone—prostate cancer	6.96e-05	0.0885	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisone—prostate cancer	6.89e-05	0.0876	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Prednisone—prostate cancer	6.54e-05	0.0832	CbGdCrCtD
Danazol—Stanozolol—AR—prostate cancer	6.4e-05	0.0346	CrCbGaD
Danazol—CCL2—Diflorasone—Prednisone—prostate cancer	6.35e-05	0.0807	CbGdCrCtD
Danazol—Ethinyl Estradiol—AOX1—prostate cancer	5.9e-05	0.0319	CrCbGaD
Danazol—Oxandrolone—AR—prostate cancer	5.76e-05	0.0311	CrCbGaD
Danazol—CCL2—Budesonide—Prednisone—prostate cancer	5.57e-05	0.0708	CbGdCrCtD
Danazol—Trilostane—ESR2—prostate cancer	5.02e-05	0.0271	CrCbGaD
Danazol—Desogestrel—SHBG—prostate cancer	4.52e-05	0.0245	CrCbGaD
Danazol—Quinestrol—ESR1—prostate cancer	4.08e-05	0.0221	CrCbGaD
Danazol—Testosterone Propionate—CYP17A1—prostate cancer	3.84e-05	0.0208	CrCbGaD
Danazol—Hydrocortisone—ANXA1—prostate cancer	3.77e-05	0.0204	CrCbGaD
Danazol—Testosterone—CYP3A43—prostate cancer	3.68e-05	0.0199	CrCbGaD
Danazol—Etonogestrel—SHBG—prostate cancer	3.66e-05	0.0198	CrCbGaD
Danazol—Testolactone—CYP19A1—prostate cancer	3.6e-05	0.0195	CrCbGaD
Danazol—CCL2—Betamethasone—Prednisone—prostate cancer	3.41e-05	0.0433	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisone—prostate cancer	3.41e-05	0.0433	CbGdCrCtD
Danazol—Testosterone Propionate—COMT—prostate cancer	3.13e-05	0.0169	CrCbGaD
Danazol—Mestranol—ESR1—prostate cancer	3.09e-05	0.0167	CrCbGaD
Danazol—Trilostane—ESR1—prostate cancer	3.09e-05	0.0167	CrCbGaD
Danazol—Desogestrel—ESR1—prostate cancer	3.06e-05	0.0165	CrCbGaD
Danazol—Levonorgestrel—SHBG—prostate cancer	2.59e-05	0.014	CrCbGaD
Danazol—Etonogestrel—ESR1—prostate cancer	2.47e-05	0.0134	CrCbGaD
Danazol—Fluoxymesterone—SHBG—prostate cancer	2.47e-05	0.0133	CrCbGaD
Danazol—Ethinyl Estradiol—ESR2—prostate cancer	2.39e-05	0.0129	CrCbGaD
Danazol—Testosterone Propionate—AR—prostate cancer	2.34e-05	0.0126	CrCbGaD
Danazol—Levonorgestrel—AR—prostate cancer	2.27e-05	0.0123	CrCbGaD
Danazol—Cortisone acetate—NR3C1—prostate cancer	2.24e-05	0.0121	CrCbGaD
Danazol—Ethinyl Estradiol—SHBG—prostate cancer	2.18e-05	0.0118	CrCbGaD
Danazol—Fluoxymesterone—AR—prostate cancer	2.17e-05	0.0117	CrCbGaD
Danazol—Dizziness—Goserelin—prostate cancer	2.15e-05	0.000429	CcSEcCtD
Danazol—Erythema multiforme—Capecitabine—prostate cancer	2.14e-05	0.000427	CcSEcCtD
Danazol—Dizziness—Conjugated Estrogens—prostate cancer	2.13e-05	0.000425	CcSEcCtD
Danazol—Convulsion—Etoposide—prostate cancer	2.12e-05	0.000423	CcSEcCtD
Danazol—Dyspepsia—Mitoxantrone—prostate cancer	2.11e-05	0.000422	CcSEcCtD
Danazol—Hypertension—Etoposide—prostate cancer	2.11e-05	0.000422	CcSEcCtD
Danazol—Norethindrone—SHBG—prostate cancer	2.1e-05	0.0113	CrCbGaD
Danazol—Flushing—Capecitabine—prostate cancer	2.1e-05	0.000419	CcSEcCtD
Danazol—Chills—Docetaxel—prostate cancer	2.09e-05	0.000418	CcSEcCtD
Danazol—Abdominal pain upper—Epirubicin—prostate cancer	2.08e-05	0.000415	CcSEcCtD
Danazol—Affect lability—Doxorubicin—prostate cancer	2.07e-05	0.000414	CcSEcCtD
Danazol—Migraine—Doxorubicin—prostate cancer	2.07e-05	0.000414	CcSEcCtD
Danazol—Fatigue—Mitoxantrone—prostate cancer	2.07e-05	0.000413	CcSEcCtD
Danazol—Vomiting—Goserelin—prostate cancer	2.06e-05	0.000413	CcSEcCtD
Danazol—Alopecia—Docetaxel—prostate cancer	2.06e-05	0.000412	CcSEcCtD
Danazol—Constipation—Mitoxantrone—prostate cancer	2.05e-05	0.00041	CcSEcCtD
Danazol—Rash—Goserelin—prostate cancer	2.05e-05	0.000409	CcSEcCtD
Danazol—Dermatitis—Goserelin—prostate cancer	2.05e-05	0.000409	CcSEcCtD
Danazol—Vomiting—Conjugated Estrogens—prostate cancer	2.05e-05	0.000409	CcSEcCtD
Danazol—Urticaria—Estradiol—prostate cancer	2.05e-05	0.000409	CcSEcCtD
Danazol—Body temperature increased—Estradiol—prostate cancer	2.04e-05	0.000407	CcSEcCtD
Danazol—Headache—Goserelin—prostate cancer	2.03e-05	0.000407	CcSEcCtD
Danazol—Rash—Conjugated Estrogens—prostate cancer	2.03e-05	0.000405	CcSEcCtD
Danazol—Chills—Capecitabine—prostate cancer	2.03e-05	0.000405	CcSEcCtD
Danazol—Dermatitis—Conjugated Estrogens—prostate cancer	2.03e-05	0.000405	CcSEcCtD
Danazol—Haemoglobin—Prednisone—prostate cancer	2.02e-05	0.000404	CcSEcCtD
Danazol—Headache—Conjugated Estrogens—prostate cancer	2.02e-05	0.000403	CcSEcCtD
Danazol—Haemorrhage—Prednisone—prostate cancer	2.01e-05	0.000402	CcSEcCtD
Danazol—Alopecia—Capecitabine—prostate cancer	2e-05	0.000399	CcSEcCtD
Danazol—Mood swings—Doxorubicin—prostate cancer	1.99e-05	0.000399	CcSEcCtD
Danazol—Methyltestosterone—SHBG—prostate cancer	1.99e-05	0.0108	CrCbGaD
Danazol—Back pain—Docetaxel—prostate cancer	1.97e-05	0.000393	CcSEcCtD
Danazol—Thrombocytopenia—Etoposide—prostate cancer	1.95e-05	0.00039	CcSEcCtD
Danazol—Muscle spasms—Docetaxel—prostate cancer	1.95e-05	0.00039	CcSEcCtD
Danazol—Tachycardia—Etoposide—prostate cancer	1.95e-05	0.000389	CcSEcCtD
Danazol—Eosinophilia—Epirubicin—prostate cancer	1.95e-05	0.000389	CcSEcCtD
Danazol—Nausea—Goserelin—prostate cancer	1.93e-05	0.000385	CcSEcCtD
Danazol—Hyperhidrosis—Etoposide—prostate cancer	1.93e-05	0.000385	CcSEcCtD
Danazol—Pancreatitis—Epirubicin—prostate cancer	1.93e-05	0.000385	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—prostate cancer	1.92e-05	0.000384	CcSEcCtD
Danazol—Nausea—Conjugated Estrogens—prostate cancer	1.91e-05	0.000382	CcSEcCtD
Danazol—Urticaria—Mitoxantrone—prostate cancer	1.91e-05	0.000381	CcSEcCtD
Danazol—Back pain—Capecitabine—prostate cancer	1.9e-05	0.00038	CcSEcCtD
Danazol—Levonorgestrel—CYP19A1—prostate cancer	1.9e-05	0.0103	CrCbGaD
Danazol—Body temperature increased—Mitoxantrone—prostate cancer	1.9e-05	0.000379	CcSEcCtD
Danazol—Muscle spasms—Capecitabine—prostate cancer	1.89e-05	0.000378	CcSEcCtD
Danazol—Flushing—Prednisone—prostate cancer	1.87e-05	0.000373	CcSEcCtD
Danazol—Vision blurred—Capecitabine—prostate cancer	1.85e-05	0.00037	CcSEcCtD
Danazol—Asthenia—Estradiol—prostate cancer	1.85e-05	0.000369	CcSEcCtD
Danazol—Tremor—Capecitabine—prostate cancer	1.84e-05	0.000368	CcSEcCtD
Danazol—Syncope—Docetaxel—prostate cancer	1.82e-05	0.000364	CcSEcCtD
Danazol—Pruritus—Estradiol—prostate cancer	1.82e-05	0.000364	CcSEcCtD
Danazol—Leukopenia—Docetaxel—prostate cancer	1.82e-05	0.000363	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—prostate cancer	1.8e-05	0.00036	CcSEcCtD
Danazol—Palpitations—Docetaxel—prostate cancer	1.8e-05	0.000359	CcSEcCtD
Danazol—Photosensitivity reaction—Epirubicin—prostate cancer	1.8e-05	0.000359	CcSEcCtD
Danazol—Paraesthesia—Etoposide—prostate cancer	1.79e-05	0.000358	CcSEcCtD
Danazol—Weight increased—Epirubicin—prostate cancer	1.79e-05	0.000358	CcSEcCtD
Danazol—Loss of consciousness—Docetaxel—prostate cancer	1.79e-05	0.000357	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—prostate cancer	1.78e-05	0.000357	CcSEcCtD
Danazol—Alopecia—Prednisone—prostate cancer	1.78e-05	0.000355	CcSEcCtD
Danazol—Vertigo—Capecitabine—prostate cancer	1.77e-05	0.000353	CcSEcCtD
Danazol—Progesterone—CYP17A1—prostate cancer	1.77e-05	0.00954	CrCbGaD
Danazol—Syncope—Capecitabine—prostate cancer	1.76e-05	0.000353	CcSEcCtD
Danazol—Leukopenia—Capecitabine—prostate cancer	1.76e-05	0.000352	CcSEcCtD
Danazol—Convulsion—Docetaxel—prostate cancer	1.76e-05	0.000352	CcSEcCtD
Danazol—Hypertension—Docetaxel—prostate cancer	1.75e-05	0.000351	CcSEcCtD
Danazol—Levonorgestrel—ESR1—prostate cancer	1.75e-05	0.00946	CrCbGaD
Danazol—Methyltestosterone—AR—prostate cancer	1.75e-05	0.00945	CrCbGaD
Danazol—Stevens-Johnson syndrome—Epirubicin—prostate cancer	1.74e-05	0.000347	CcSEcCtD
Danazol—Palpitations—Capecitabine—prostate cancer	1.74e-05	0.000347	CcSEcCtD
Danazol—Arthralgia—Docetaxel—prostate cancer	1.73e-05	0.000346	CcSEcCtD
Danazol—Loss of consciousness—Capecitabine—prostate cancer	1.73e-05	0.000345	CcSEcCtD
Danazol—Asthenia—Mitoxantrone—prostate cancer	1.72e-05	0.000344	CcSEcCtD
Danazol—Fatigue—Etoposide—prostate cancer	1.72e-05	0.000344	CcSEcCtD
Danazol—Jaundice—Epirubicin—prostate cancer	1.71e-05	0.000342	CcSEcCtD
Danazol—Constipation—Etoposide—prostate cancer	1.71e-05	0.000341	CcSEcCtD
Danazol—Dizziness—Estradiol—prostate cancer	1.7e-05	0.00034	CcSEcCtD
Danazol—Hypertension—Capecitabine—prostate cancer	1.7e-05	0.000339	CcSEcCtD
Danazol—Progesterone—SLC22A3—prostate cancer	1.68e-05	0.0091	CrCbGaD
Danazol—Sweating—Epirubicin—prostate cancer	1.68e-05	0.000336	CcSEcCtD
Danazol—Arthralgia—Capecitabine—prostate cancer	1.67e-05	0.000335	CcSEcCtD
Danazol—Haematuria—Epirubicin—prostate cancer	1.67e-05	0.000334	CcSEcCtD
Danazol—Norethindrone—CYP3A5—prostate cancer	1.67e-05	0.00904	CrCbGaD
Danazol—Anxiety—Capecitabine—prostate cancer	1.67e-05	0.000333	CcSEcCtD
Danazol—Fluoxymesterone—ESR1—prostate cancer	1.67e-05	0.00901	CrCbGaD
Danazol—Photosensitivity reaction—Doxorubicin—prostate cancer	1.66e-05	0.000332	CcSEcCtD
Danazol—Oedema—Docetaxel—prostate cancer	1.66e-05	0.000331	CcSEcCtD
Danazol—Weight increased—Doxorubicin—prostate cancer	1.66e-05	0.000331	CcSEcCtD
Danazol—Vision blurred—Prednisone—prostate cancer	1.65e-05	0.00033	CcSEcCtD
Danazol—Vomiting—Estradiol—prostate cancer	1.64e-05	0.000327	CcSEcCtD
Danazol—Shock—Docetaxel—prostate cancer	1.63e-05	0.000326	CcSEcCtD
Danazol—Thrombocytopenia—Docetaxel—prostate cancer	1.62e-05	0.000324	CcSEcCtD
Danazol—Rash—Estradiol—prostate cancer	1.62e-05	0.000324	CcSEcCtD
Danazol—Dermatitis—Estradiol—prostate cancer	1.62e-05	0.000324	CcSEcCtD
Danazol—Tachycardia—Docetaxel—prostate cancer	1.62e-05	0.000323	CcSEcCtD
Danazol—Headache—Estradiol—prostate cancer	1.61e-05	0.000322	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	1.61e-05	0.000321	CcSEcCtD
Danazol—Oedema—Capecitabine—prostate cancer	1.61e-05	0.000321	CcSEcCtD
Danazol—Testosterone—SLC22A3—prostate cancer	1.59e-05	0.0086	CrCbGaD
Danazol—Urticaria—Etoposide—prostate cancer	1.59e-05	0.000317	CcSEcCtD
Danazol—Haemoglobin—Epirubicin—prostate cancer	1.58e-05	0.000316	CcSEcCtD
Danazol—Jaundice—Doxorubicin—prostate cancer	1.58e-05	0.000316	CcSEcCtD
Danazol—Shock—Capecitabine—prostate cancer	1.58e-05	0.000316	CcSEcCtD
Danazol—Body temperature increased—Etoposide—prostate cancer	1.58e-05	0.000315	CcSEcCtD
Danazol—Vertigo—Prednisone—prostate cancer	1.57e-05	0.000315	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—prostate cancer	1.57e-05	0.000315	CcSEcCtD
Danazol—Thrombocytopenia—Capecitabine—prostate cancer	1.57e-05	0.000314	CcSEcCtD
Danazol—Syncope—Prednisone—prostate cancer	1.57e-05	0.000314	CcSEcCtD
Danazol—Tachycardia—Capecitabine—prostate cancer	1.57e-05	0.000313	CcSEcCtD
Danazol—Sweating—Doxorubicin—prostate cancer	1.56e-05	0.000311	CcSEcCtD
Danazol—Hyperhidrosis—Capecitabine—prostate cancer	1.55e-05	0.00031	CcSEcCtD
Danazol—Haematuria—Doxorubicin—prostate cancer	1.55e-05	0.000309	CcSEcCtD
Danazol—Loss of consciousness—Prednisone—prostate cancer	1.54e-05	0.000308	CcSEcCtD
Danazol—Nausea—Estradiol—prostate cancer	1.53e-05	0.000306	CcSEcCtD
Danazol—Vomiting—Mitoxantrone—prostate cancer	1.53e-05	0.000305	CcSEcCtD
Danazol—Convulsion—Prednisone—prostate cancer	1.52e-05	0.000303	CcSEcCtD
Danazol—Visual impairment—Epirubicin—prostate cancer	1.52e-05	0.000303	CcSEcCtD
Danazol—Hypertension—Prednisone—prostate cancer	1.51e-05	0.000302	CcSEcCtD
Danazol—Rash—Mitoxantrone—prostate cancer	1.51e-05	0.000302	CcSEcCtD
Danazol—Dermatitis—Mitoxantrone—prostate cancer	1.51e-05	0.000302	CcSEcCtD
Danazol—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.51e-05	0.000302	CcSEcCtD
Danazol—Headache—Mitoxantrone—prostate cancer	1.5e-05	0.0003	CcSEcCtD
Danazol—Hydrocortisone—SHBG—prostate cancer	1.5e-05	0.00812	CrCbGaD
Danazol—Arthralgia—Prednisone—prostate cancer	1.49e-05	0.000298	CcSEcCtD
Danazol—Paraesthesia—Docetaxel—prostate cancer	1.49e-05	0.000298	CcSEcCtD
Danazol—Erythema multiforme—Epirubicin—prostate cancer	1.49e-05	0.000297	CcSEcCtD
Danazol—Anxiety—Prednisone—prostate cancer	1.49e-05	0.000297	CcSEcCtD
Danazol—Ethinyl Estradiol—ESR1—prostate cancer	1.47e-05	0.00797	CrCbGaD
Danazol—Fluoxymesterone—NR3C1—prostate cancer	1.47e-05	0.00794	CrCbGaD
Danazol—Haemoglobin—Doxorubicin—prostate cancer	1.46e-05	0.000293	CcSEcCtD
Danazol—Methyltestosterone—CYP19A1—prostate cancer	1.46e-05	0.00791	CrCbGaD
Danazol—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.46e-05	0.000292	CcSEcCtD
Danazol—Flushing—Epirubicin—prostate cancer	1.46e-05	0.000292	CcSEcCtD
Danazol—Dyspepsia—Docetaxel—prostate cancer	1.46e-05	0.000292	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—prostate cancer	1.46e-05	0.000291	CcSEcCtD
Danazol—Paraesthesia—Capecitabine—prostate cancer	1.44e-05	0.000288	CcSEcCtD
Danazol—Asthenia—Etoposide—prostate cancer	1.43e-05	0.000286	CcSEcCtD
Danazol—Oedema—Prednisone—prostate cancer	1.43e-05	0.000286	CcSEcCtD
Danazol—Fatigue—Docetaxel—prostate cancer	1.43e-05	0.000286	CcSEcCtD
Danazol—Nausea—Mitoxantrone—prostate cancer	1.42e-05	0.000285	CcSEcCtD
Danazol—Constipation—Docetaxel—prostate cancer	1.42e-05	0.000283	CcSEcCtD
Danazol—Dyspepsia—Capecitabine—prostate cancer	1.41e-05	0.000282	CcSEcCtD
Danazol—Chills—Epirubicin—prostate cancer	1.41e-05	0.000282	CcSEcCtD
Danazol—Pruritus—Etoposide—prostate cancer	1.41e-05	0.000282	CcSEcCtD
Danazol—Shock—Prednisone—prostate cancer	1.41e-05	0.000281	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—prostate cancer	1.4e-05	0.000281	CcSEcCtD
Danazol—Tachycardia—Prednisone—prostate cancer	1.4e-05	0.000279	CcSEcCtD
Danazol—Alopecia—Epirubicin—prostate cancer	1.39e-05	0.000278	CcSEcCtD
Danazol—Fatigue—Capecitabine—prostate cancer	1.38e-05	0.000277	CcSEcCtD
Danazol—Hyperhidrosis—Prednisone—prostate cancer	1.38e-05	0.000276	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—prostate cancer	1.38e-05	0.000275	CcSEcCtD
Danazol—Constipation—Capecitabine—prostate cancer	1.37e-05	0.000274	CcSEcCtD
Danazol—Flushing—Doxorubicin—prostate cancer	1.35e-05	0.00027	CcSEcCtD
Danazol—Tension—Epirubicin—prostate cancer	1.34e-05	0.000269	CcSEcCtD
Danazol—Nervousness—Epirubicin—prostate cancer	1.33e-05	0.000266	CcSEcCtD
Danazol—Back pain—Epirubicin—prostate cancer	1.33e-05	0.000265	CcSEcCtD
Danazol—Dizziness—Etoposide—prostate cancer	1.32e-05	0.000264	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—prostate cancer	1.32e-05	0.000263	CcSEcCtD
Danazol—Body temperature increased—Docetaxel—prostate cancer	1.31e-05	0.000262	CcSEcCtD
Danazol—Chills—Doxorubicin—prostate cancer	1.31e-05	0.000261	CcSEcCtD
Danazol—Musculoskeletal discomfort—Prednisone—prostate cancer	1.3e-05	0.00026	CcSEcCtD
Danazol—Cortisone acetate—CYP3A4—prostate cancer	1.3e-05	0.00703	CrCbGaD
Danazol—Vision blurred—Epirubicin—prostate cancer	1.29e-05	0.000258	CcSEcCtD
Danazol—Alopecia—Doxorubicin—prostate cancer	1.29e-05	0.000257	CcSEcCtD
Danazol—Paraesthesia—Prednisone—prostate cancer	1.28e-05	0.000257	CcSEcCtD
Danazol—Urticaria—Capecitabine—prostate cancer	1.28e-05	0.000255	CcSEcCtD
Danazol—Body temperature increased—Capecitabine—prostate cancer	1.27e-05	0.000254	CcSEcCtD
Danazol—Vomiting—Etoposide—prostate cancer	1.27e-05	0.000254	CcSEcCtD
Danazol—Prednisone—NR3C1—prostate cancer	1.27e-05	0.00685	CrCbGaD
Danazol—Etonogestrel—CYP3A4—prostate cancer	1.26e-05	0.00682	CrCbGaD
Danazol—Dyspepsia—Prednisone—prostate cancer	1.26e-05	0.000252	CcSEcCtD
Danazol—Rash—Etoposide—prostate cancer	1.26e-05	0.000251	CcSEcCtD
Danazol—Dermatitis—Etoposide—prostate cancer	1.26e-05	0.000251	CcSEcCtD
Danazol—Headache—Etoposide—prostate cancer	1.25e-05	0.00025	CcSEcCtD
Danazol—Tension—Doxorubicin—prostate cancer	1.24e-05	0.000249	CcSEcCtD
Danazol—Fatigue—Prednisone—prostate cancer	1.23e-05	0.000246	CcSEcCtD
Danazol—Nervousness—Doxorubicin—prostate cancer	1.23e-05	0.000246	CcSEcCtD
Danazol—Vertigo—Epirubicin—prostate cancer	1.23e-05	0.000246	CcSEcCtD
Danazol—Syncope—Epirubicin—prostate cancer	1.23e-05	0.000246	CcSEcCtD
Danazol—Leukopenia—Epirubicin—prostate cancer	1.23e-05	0.000245	CcSEcCtD
Danazol—Back pain—Doxorubicin—prostate cancer	1.23e-05	0.000245	CcSEcCtD
Danazol—Progesterone—SHBG—prostate cancer	1.22e-05	0.00661	CrCbGaD
Danazol—Progesterone—CYP1B1—prostate cancer	1.22e-05	0.00661	CrCbGaD
Danazol—Constipation—Prednisone—prostate cancer	1.22e-05	0.000244	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—prostate cancer	1.22e-05	0.000244	CcSEcCtD
Danazol—Palpitations—Epirubicin—prostate cancer	1.21e-05	0.000242	CcSEcCtD
Danazol—Progesterone—SLC22A1—prostate cancer	1.21e-05	0.00653	CrCbGaD
Danazol—Loss of consciousness—Epirubicin—prostate cancer	1.2e-05	0.000241	CcSEcCtD
Danazol—Hydrocortisone—CYP3A5—prostate cancer	1.2e-05	0.00646	CrCbGaD
Danazol—Vision blurred—Doxorubicin—prostate cancer	1.2e-05	0.000239	CcSEcCtD
Danazol—Asthenia—Docetaxel—prostate cancer	1.19e-05	0.000238	CcSEcCtD
Danazol—Convulsion—Epirubicin—prostate cancer	1.19e-05	0.000237	CcSEcCtD
Danazol—Nausea—Etoposide—prostate cancer	1.19e-05	0.000237	CcSEcCtD
Danazol—Hypertension—Epirubicin—prostate cancer	1.18e-05	0.000236	CcSEcCtD
Danazol—Pruritus—Docetaxel—prostate cancer	1.17e-05	0.000234	CcSEcCtD
Danazol—Arthralgia—Epirubicin—prostate cancer	1.17e-05	0.000233	CcSEcCtD
Danazol—Anxiety—Epirubicin—prostate cancer	1.16e-05	0.000232	CcSEcCtD
Danazol—Testosterone—SHBG—prostate cancer	1.16e-05	0.00625	CrCbGaD
Danazol—Testosterone—CYP1B1—prostate cancer	1.16e-05	0.00625	CrCbGaD
Danazol—Prednisone—CYP2C19—prostate cancer	1.15e-05	0.00624	CrCbGaD
Danazol—Asthenia—Capecitabine—prostate cancer	1.15e-05	0.00023	CcSEcCtD
Danazol—Testosterone—SLC22A1—prostate cancer	1.14e-05	0.00617	CrCbGaD
Danazol—Vertigo—Doxorubicin—prostate cancer	1.14e-05	0.000228	CcSEcCtD
Danazol—Norethindrone—CYP2C19—prostate cancer	1.14e-05	0.00615	CrCbGaD
Danazol—Syncope—Doxorubicin—prostate cancer	1.14e-05	0.000227	CcSEcCtD
Danazol—Urticaria—Prednisone—prostate cancer	1.14e-05	0.000227	CcSEcCtD
Danazol—Pruritus—Capecitabine—prostate cancer	1.14e-05	0.000227	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—prostate cancer	1.14e-05	0.000227	CcSEcCtD
Danazol—Body temperature increased—Prednisone—prostate cancer	1.13e-05	0.000226	CcSEcCtD
Danazol—Palpitations—Doxorubicin—prostate cancer	1.12e-05	0.000224	CcSEcCtD
Danazol—Oedema—Epirubicin—prostate cancer	1.12e-05	0.000223	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—prostate cancer	1.11e-05	0.000223	CcSEcCtD
Danazol—Shock—Epirubicin—prostate cancer	1.1e-05	0.00022	CcSEcCtD
Danazol—Convulsion—Doxorubicin—prostate cancer	1.1e-05	0.00022	CcSEcCtD
Danazol—Dizziness—Docetaxel—prostate cancer	1.1e-05	0.000219	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—prostate cancer	1.1e-05	0.000219	CcSEcCtD
Danazol—Hypertension—Doxorubicin—prostate cancer	1.09e-05	0.000219	CcSEcCtD
Danazol—Tachycardia—Epirubicin—prostate cancer	1.09e-05	0.000218	CcSEcCtD
Danazol—Hyperhidrosis—Epirubicin—prostate cancer	1.08e-05	0.000216	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—prostate cancer	1.08e-05	0.000216	CcSEcCtD
Danazol—Anxiety—Doxorubicin—prostate cancer	1.08e-05	0.000215	CcSEcCtD
Danazol—Progesterone—AR—prostate cancer	1.07e-05	0.0058	CrCbGaD
Danazol—Dizziness—Capecitabine—prostate cancer	1.06e-05	0.000212	CcSEcCtD
Danazol—Vomiting—Docetaxel—prostate cancer	1.05e-05	0.000211	CcSEcCtD
Danazol—Rash—Docetaxel—prostate cancer	1.05e-05	0.000209	CcSEcCtD
Danazol—Dermatitis—Docetaxel—prostate cancer	1.04e-05	0.000209	CcSEcCtD
Danazol—Headache—Docetaxel—prostate cancer	1.04e-05	0.000208	CcSEcCtD
Danazol—Oedema—Doxorubicin—prostate cancer	1.03e-05	0.000207	CcSEcCtD
Danazol—Asthenia—Prednisone—prostate cancer	1.03e-05	0.000205	CcSEcCtD
Danazol—Vomiting—Capecitabine—prostate cancer	1.02e-05	0.000204	CcSEcCtD
Danazol—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.02e-05	0.000204	CcSEcCtD
Danazol—Shock—Doxorubicin—prostate cancer	1.02e-05	0.000203	CcSEcCtD
Danazol—Testosterone—AR—prostate cancer	1.01e-05	0.00548	CrCbGaD
Danazol—Thrombocytopenia—Doxorubicin—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Danazol—Rash—Capecitabine—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Danazol—Pruritus—Prednisone—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Danazol—Dermatitis—Capecitabine—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—prostate cancer	1.01e-05	0.000202	CcSEcCtD
Danazol—Headache—Capecitabine—prostate cancer	1.01e-05	0.000201	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—prostate cancer	1e-05	0.000201	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—prostate cancer	1e-05	0.0002	CcSEcCtD
Danazol—Nausea—Docetaxel—prostate cancer	9.85e-06	0.000197	CcSEcCtD
Danazol—Dyspepsia—Epirubicin—prostate cancer	9.85e-06	0.000197	CcSEcCtD
Danazol—Progesterone—CYP3A5—prostate cancer	9.74e-06	0.00527	CrCbGaD
Danazol—Fatigue—Epirubicin—prostate cancer	9.64e-06	0.000193	CcSEcCtD
Danazol—Constipation—Epirubicin—prostate cancer	9.56e-06	0.000191	CcSEcCtD
Danazol—Nausea—Capecitabine—prostate cancer	9.54e-06	0.000191	CcSEcCtD
Danazol—Dizziness—Prednisone—prostate cancer	9.46e-06	0.000189	CcSEcCtD
Danazol—Progesterone—CYP2A6—prostate cancer	9.43e-06	0.0051	CrCbGaD
Danazol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.43e-06	0.000188	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—prostate cancer	9.29e-06	0.000186	CcSEcCtD
Danazol—Testosterone—CYP3A5—prostate cancer	9.21e-06	0.00498	CrCbGaD
Danazol—Dyspepsia—Doxorubicin—prostate cancer	9.11e-06	0.000182	CcSEcCtD
Danazol—Vomiting—Prednisone—prostate cancer	9.09e-06	0.000182	CcSEcCtD
Danazol—Rash—Prednisone—prostate cancer	9.02e-06	0.00018	CcSEcCtD
Danazol—Dermatitis—Prednisone—prostate cancer	9.01e-06	0.00018	CcSEcCtD
Danazol—Headache—Prednisone—prostate cancer	8.96e-06	0.000179	CcSEcCtD
Danazol—Levonorgestrel—CYP3A4—prostate cancer	8.93e-06	0.00483	CrCbGaD
Danazol—Hydrocortisone—NR3C1—prostate cancer	8.93e-06	0.00483	CrCbGaD
Danazol—Fatigue—Doxorubicin—prostate cancer	8.92e-06	0.000178	CcSEcCtD
Danazol—Urticaria—Epirubicin—prostate cancer	8.89e-06	0.000178	CcSEcCtD
Danazol—Constipation—Doxorubicin—prostate cancer	8.85e-06	0.000177	CcSEcCtD
Danazol—Body temperature increased—Epirubicin—prostate cancer	8.84e-06	0.000177	CcSEcCtD
Danazol—Nausea—Prednisone—prostate cancer	8.49e-06	0.00017	CcSEcCtD
Danazol—Testosterone—CYP19A1—prostate cancer	8.49e-06	0.00459	CrCbGaD
Danazol—Progesterone—ESR1—prostate cancer	8.26e-06	0.00447	CrCbGaD
Danazol—Urticaria—Doxorubicin—prostate cancer	8.22e-06	0.000164	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—prostate cancer	8.18e-06	0.000163	CcSEcCtD
Danazol—Asthenia—Epirubicin—prostate cancer	8.02e-06	0.00016	CcSEcCtD
Danazol—Pruritus—Epirubicin—prostate cancer	7.91e-06	0.000158	CcSEcCtD
Danazol—Ethinyl Estradiol—CYP3A4—prostate cancer	7.53e-06	0.00407	CrCbGaD
Danazol—Asthenia—Doxorubicin—prostate cancer	7.43e-06	0.000148	CcSEcCtD
Danazol—Dizziness—Epirubicin—prostate cancer	7.4e-06	0.000148	CcSEcCtD
Danazol—Prednisone—CYP3A4—prostate cancer	7.34e-06	0.00397	CrCbGaD
Danazol—Pruritus—Doxorubicin—prostate cancer	7.32e-06	0.000146	CcSEcCtD
Danazol—Progesterone—NR3C1—prostate cancer	7.28e-06	0.00393	CrCbGaD
Danazol—Norethindrone—CYP3A4—prostate cancer	7.24e-06	0.00391	CrCbGaD
Danazol—Vomiting—Epirubicin—prostate cancer	7.11e-06	0.000142	CcSEcCtD
Danazol—Rash—Epirubicin—prostate cancer	7.05e-06	0.000141	CcSEcCtD
Danazol—Dermatitis—Epirubicin—prostate cancer	7.05e-06	0.000141	CcSEcCtD
Danazol—Headache—Epirubicin—prostate cancer	7.01e-06	0.00014	CcSEcCtD
Danazol—Methyltestosterone—CYP3A4—prostate cancer	6.87e-06	0.00371	CrCbGaD
Danazol—Dizziness—Doxorubicin—prostate cancer	6.84e-06	0.000137	CcSEcCtD
Danazol—Nausea—Epirubicin—prostate cancer	6.64e-06	0.000133	CcSEcCtD
Danazol—Progesterone—CYP2C19—prostate cancer	6.63e-06	0.00358	CrCbGaD
Danazol—Progesterone—CYP1A1—prostate cancer	6.61e-06	0.00357	CrCbGaD
Danazol—Vomiting—Doxorubicin—prostate cancer	6.58e-06	0.000131	CcSEcCtD
Danazol—Rash—Doxorubicin—prostate cancer	6.53e-06	0.00013	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—prostate cancer	6.52e-06	0.00013	CcSEcCtD
Danazol—Headache—Doxorubicin—prostate cancer	6.48e-06	0.00013	CcSEcCtD
Danazol—Testosterone—CYP2C19—prostate cancer	6.27e-06	0.00339	CrCbGaD
Danazol—Testosterone—CYP1A1—prostate cancer	6.25e-06	0.00338	CrCbGaD
Danazol—Nausea—Doxorubicin—prostate cancer	6.15e-06	0.000123	CcSEcCtD
Danazol—Hydrocortisone—CYP3A4—prostate cancer	5.18e-06	0.0028	CrCbGaD
Danazol—Progesterone—CYP3A4—prostate cancer	4.22e-06	0.00228	CrCbGaD
Danazol—Testosterone—CYP3A4—prostate cancer	3.99e-06	0.00215	CrCbGaD
Danazol—GNRHR—Signaling Pathways—IL2—prostate cancer	1.45e-06	3.65e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.44e-06	3.64e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—prostate cancer	1.44e-06	3.63e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—prostate cancer	1.44e-06	3.63e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CAV1—prostate cancer	1.43e-06	3.59e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EP300—prostate cancer	1.42e-06	3.58e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—prostate cancer	1.41e-06	3.56e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—CREBBP—prostate cancer	1.41e-06	3.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.41e-06	3.55e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—prostate cancer	1.41e-06	3.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR4—prostate cancer	1.4e-06	3.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PARP1—prostate cancer	1.4e-06	3.54e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—prostate cancer	1.4e-06	3.53e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMS—prostate cancer	1.39e-06	3.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CALCA—prostate cancer	1.39e-06	3.49e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—prostate cancer	1.38e-06	3.48e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ESR1—prostate cancer	1.37e-06	3.46e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—prostate cancer	1.37e-06	3.46e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—prostate cancer	1.37e-06	3.46e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARA—prostate cancer	1.37e-06	3.45e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—prostate cancer	1.37e-06	3.44e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—prostate cancer	1.36e-06	3.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL12—prostate cancer	1.35e-06	3.41e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—prostate cancer	1.35e-06	3.39e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LPL—prostate cancer	1.35e-06	3.39e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BAD—prostate cancer	1.34e-06	3.38e-05	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—prostate cancer	1.34e-06	3.38e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—prostate cancer	1.33e-06	3.36e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—prostate cancer	1.33e-06	3.35e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—prostate cancer	1.32e-06	3.33e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EP300—prostate cancer	1.3e-06	3.28e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—prostate cancer	1.3e-06	3.28e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—prostate cancer	1.3e-06	3.27e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—prostate cancer	1.3e-06	3.27e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ERCC2—prostate cancer	1.29e-06	3.25e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGF—prostate cancer	1.28e-06	3.23e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS1—prostate cancer	1.28e-06	3.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP9—prostate cancer	1.28e-06	3.21e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—prostate cancer	1.26e-06	3.19e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HPGD—prostate cancer	1.26e-06	3.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.26e-06	3.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GSK3B—prostate cancer	1.25e-06	3.14e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—prostate cancer	1.24e-06	3.12e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCQ—prostate cancer	1.24e-06	3.11e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—prostate cancer	1.24e-06	3.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGFR—prostate cancer	1.24e-06	3.11e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—prostate cancer	1.23e-06	3.1e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INS—prostate cancer	1.23e-06	3.1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAP3K7—prostate cancer	1.22e-06	3.08e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—prostate cancer	1.22e-06	3.07e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—prostate cancer	1.21e-06	3.05e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—prostate cancer	1.21e-06	3.05e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREBBP—prostate cancer	1.2e-06	3.03e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—prostate cancer	1.19e-06	3e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARA—prostate cancer	1.19e-06	3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.18e-06	2.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF10—prostate cancer	1.17e-06	2.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB2—prostate cancer	1.16e-06	2.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTAP—prostate cancer	1.15e-06	2.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.15e-06	2.9e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAP2K1—prostate cancer	1.15e-06	2.9e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—prostate cancer	1.15e-06	2.88e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CD—prostate cancer	1.14e-06	2.88e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VAV3—prostate cancer	1.13e-06	2.86e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—prostate cancer	1.13e-06	2.86e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—prostate cancer	1.13e-06	2.85e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—prostate cancer	1.13e-06	2.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.12e-06	2.82e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.12e-06	2.82e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAV1—prostate cancer	1.12e-06	2.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFBR2—prostate cancer	1.12e-06	2.81e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—prostate cancer	1.11e-06	2.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ITPR1—prostate cancer	1.1e-06	2.77e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—prostate cancer	1.1e-06	2.77e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF2—prostate cancer	1.09e-06	2.75e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CREBBP—prostate cancer	1.09e-06	2.74e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—prostate cancer	1.08e-06	2.72e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACSL4—prostate cancer	1.07e-06	2.69e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.07e-06	2.69e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.07e-06	2.69e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—prostate cancer	1.05e-06	2.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—prostate cancer	1.05e-06	2.65e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JAK2—prostate cancer	1.05e-06	2.64e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—prostate cancer	1.05e-06	2.64e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PHGDH—prostate cancer	1.03e-06	2.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ARG2—prostate cancer	1.03e-06	2.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UMPS—prostate cancer	1.03e-06	2.58e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MDM2—prostate cancer	1.02e-06	2.58e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—prostate cancer	1.02e-06	2.57e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—prostate cancer	1.02e-06	2.57e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—prostate cancer	1.02e-06	2.56e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—prostate cancer	1.01e-06	2.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LPL—prostate cancer	1.01e-06	2.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LDHB—prostate cancer	1.01e-06	2.53e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFRB—prostate cancer	9.99e-07	2.52e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CB—prostate cancer	9.95e-07	2.51e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.87e-07	2.49e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ITGB3—prostate cancer	9.73e-07	2.45e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INS—prostate cancer	9.64e-07	2.43e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—prostate cancer	9.62e-07	2.42e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—prostate cancer	9.56e-07	2.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UCP3—prostate cancer	9.53e-07	2.4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA3—prostate cancer	9.53e-07	2.4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PDHA1—prostate cancer	9.53e-07	2.4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TCN2—prostate cancer	9.53e-07	2.4e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CREBBP—prostate cancer	9.44e-07	2.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB3—prostate cancer	9.44e-07	2.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR2—prostate cancer	9.43e-07	2.37e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1B—prostate cancer	9.34e-07	2.35e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—prostate cancer	9.32e-07	2.35e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—prostate cancer	9.31e-07	2.35e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—prostate cancer	9.15e-07	2.31e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—prostate cancer	9.14e-07	2.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.09e-07	2.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.09e-07	2.29e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TERT—prostate cancer	9.05e-07	2.28e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CD—prostate cancer	8.95e-07	2.26e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—prostate cancer	8.91e-07	2.25e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—prostate cancer	8.82e-07	2.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA4—prostate cancer	8.72e-07	2.2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.72e-07	2.2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIF1A—prostate cancer	8.65e-07	2.18e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—prostate cancer	8.65e-07	2.18e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—prostate cancer	8.62e-07	2.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—prostate cancer	8.6e-07	2.17e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—prostate cancer	8.59e-07	2.17e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—prostate cancer	8.52e-07	2.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA2—prostate cancer	8.49e-07	2.14e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—prostate cancer	8.45e-07	2.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—prostate cancer	8.45e-07	2.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCG5—prostate cancer	8.39e-07	2.11e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.39e-07	2.11e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—prostate cancer	8.38e-07	2.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CAV1—prostate cancer	8.37e-07	2.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—prostate cancer	8.28e-07	2.09e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EP300—prostate cancer	8.2e-07	2.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA1—prostate cancer	8.2e-07	2.06e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAT2—prostate cancer	8.1e-07	2.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.1e-07	2.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTO1—prostate cancer	8.1e-07	2.04e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—prostate cancer	7.98e-07	2.01e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BAD—prostate cancer	7.87e-07	1.98e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—prostate cancer	7.86e-07	1.98e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CB—prostate cancer	7.8e-07	1.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LRP2—prostate cancer	7.77e-07	1.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLCB2—prostate cancer	7.77e-07	1.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.77e-07	1.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—prostate cancer	7.77e-07	1.96e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—prostate cancer	7.73e-07	1.95e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—prostate cancer	7.69e-07	1.94e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—prostate cancer	7.62e-07	1.92e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—prostate cancer	7.62e-07	1.92e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—prostate cancer	7.62e-07	1.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—P4HB—prostate cancer	7.62e-07	1.92e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGF—prostate cancer	7.54e-07	1.9e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS1—prostate cancer	7.54e-07	1.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.41e-07	1.87e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GSK3B—prostate cancer	7.32e-07	1.84e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.22e-07	1.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INS—prostate cancer	7.22e-07	1.82e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—prostate cancer	7.15e-07	1.8e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—prostate cancer	7.13e-07	1.8e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MED12—prostate cancer	7.11e-07	1.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREBBP—prostate cancer	7.07e-07	1.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNG5—prostate cancer	7.05e-07	1.78e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—prostate cancer	6.99e-07	1.76e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—prostate cancer	6.98e-07	1.76e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA3—prostate cancer	6.79e-07	1.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAP2K1—prostate cancer	6.75e-07	1.7e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—prostate cancer	6.74e-07	1.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CD—prostate cancer	6.7e-07	1.69e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—prostate cancer	6.63e-07	1.67e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—prostate cancer	6.6e-07	1.66e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HPGDS—prostate cancer	6.48e-07	1.63e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—prostate cancer	6.45e-07	1.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.44e-07	1.62e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—EP300—prostate cancer	6.43e-07	1.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF2—prostate cancer	6.42e-07	1.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—prostate cancer	6.33e-07	1.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—prostate cancer	6.28e-07	1.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACHE—prostate cancer	6.28e-07	1.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.21e-07	1.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JAK2—prostate cancer	6.15e-07	1.55e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—prostate cancer	6.07e-07	1.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.04e-07	1.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PRKACB—prostate cancer	6.01e-07	1.51e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MDM2—prostate cancer	6e-07	1.51e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.95e-07	1.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—prostate cancer	5.92e-07	1.49e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—prostate cancer	5.87e-07	1.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CB—prostate cancer	5.84e-07	1.47e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—prostate cancer	5.81e-07	1.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA2—prostate cancer	5.67e-07	1.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—prostate cancer	5.61e-07	1.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1B—prostate cancer	5.48e-07	1.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.41e-07	1.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—prostate cancer	5.37e-07	1.35e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—prostate cancer	5.37e-07	1.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—prostate cancer	5.36e-07	1.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.28e-07	1.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—prostate cancer	5.23e-07	1.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NQO1—prostate cancer	5.22e-07	1.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—prostate cancer	5.18e-07	1.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TH—prostate cancer	5.15e-07	1.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—prostate cancer	5.08e-07	1.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—prostate cancer	5.06e-07	1.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—prostate cancer	5.05e-07	1.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.01e-07	1.26e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—prostate cancer	4.96e-07	1.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGT1—prostate cancer	4.85e-07	1.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EP300—prostate cancer	4.81e-07	1.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA1—prostate cancer	4.78e-07	1.2e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—prostate cancer	4.76e-07	1.2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.71e-07	1.19e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—prostate cancer	4.68e-07	1.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—prostate cancer	4.56e-07	1.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RXRA—prostate cancer	4.54e-07	1.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—prostate cancer	4.51e-07	1.14e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—prostate cancer	4.47e-07	1.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COMT—prostate cancer	4.38e-07	1.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—prostate cancer	4.36e-07	1.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ITPR1—prostate cancer	4.29e-07	1.08e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—prostate cancer	4.19e-07	1.06e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—prostate cancer	4.18e-07	1.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—prostate cancer	4.1e-07	1.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMS—prostate cancer	4.05e-07	1.02e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—prostate cancer	4e-07	1.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPL—prostate cancer	3.93e-07	9.9e-06	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—prostate cancer	3.89e-07	9.79e-06	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—prostate cancer	3.88e-07	9.77e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.79e-07	9.56e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ERCC2—prostate cancer	3.76e-07	9.48e-06	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—prostate cancer	3.56e-07	8.97e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—prostate cancer	3.54e-07	8.91e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARA—prostate cancer	3.47e-07	8.74e-06	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—prostate cancer	3.44e-07	8.68e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAV1—prostate cancer	3.26e-07	8.22e-06	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—prostate cancer	3.15e-07	7.94e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.97e-07	7.49e-06	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—prostate cancer	2.91e-07	7.33e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INS—prostate cancer	2.81e-07	7.09e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CREBBP—prostate cancer	2.76e-07	6.94e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.61e-07	6.58e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—prostate cancer	2.47e-07	6.22e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.28e-07	5.74e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—prostate cancer	2.26e-07	5.69e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—prostate cancer	1.97e-07	4.96e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EP300—prostate cancer	1.88e-07	4.73e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.39e-07	3.5e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—prostate cancer	1.13e-07	2.86e-06	CbGpPWpGaD
